Volume 14, Issue 4 (Jul-Aug 2020)                   mljgoums 2020, 14(4): 27-30 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mirshekar Z, Behnampour N, Amini A, Alizad G, kouchaki G M, Niknejad F. Screening for Azole Resistance among Aspergillus spp isolated from Soil of Hospitals and a University Campus in Gorgan, Iran. mljgoums. 2020; 14 (4) :27-30
URL: http://mlj.goums.ac.ir/article-1-1254-en.html
1- Student Research Committee, Golestan University of Medical Sciences, Gorgan, Iran
2- Faculty of Health, Department of Biostatistics, Golestan University of Medical Sciences, Gorgan, Iran
3- Laboratory Sciences Research Center, Golestan University of Medical Sciences, Gorgan, Iran
4- Laboratory Sciences Research Center, Golestan University of Medical Sciences, Gorgan, Iran , fniknezhad@yahoo.com
Abstract:   (645 Views)
Background and objectives: Aspergillosis is a widely distributed infectious disease, which is difficult to manage. According to recent studies, the prevalence of resistant Aspergillus fumigatus has increased from 3.3% to 6.6%. Acquired triazole resistance in Aspergillus species is an evolving global health challenge, which has made the control of diseases caused by Aspergillus a concern. This study was performed to investigate prevalence of azole resistance in Aspergillus isolates from environmental samples.
      Methods: In this study, 316 soil samples were collected from three hospitals and a university campus in Gorgan (Iran) from July to September 2017. Two grams of each sample were suspended in 5 ml of 0.2M NaCl with 1% Tween 20. Then, 100 µl of the suspension was plated on sabouraud dextrose agar (SDA) supplemented with chloramphenicol, SDA supplemented with chloramphenicol and voriconazole (VOR, 1 mg/L) and SDA supplemented with chloramphenicol and itraconazole (ITC, 4 mg/L). The plates were incubated at 37 °C and examined for growth after 24, 48 and 72 hours.
      Results: We detected Aspergillus fumigatus, Aspergillus flavus, Aspergillus niger and Aspergillus nidulans isolates in 187(59.2%), 84(26.6%), 147(46.5%) and 65(20.6%) samples, respectively. We found no VOR resistant isolate. However, 21 (25%) A. flavus and 16 (8.6%) A. fumigatus isolates were intermediate for VOR. In addition, seven (8.3%) A. flavus, 68 (36.4%) A. fumigatus, 41 (27.9%) A. niger and three (4.5%) A. nidulans isolates were resistant to ITC.
      Conclusion: We were able to detect A.fumigatus, A. flavus, A. niger from all four sampling sites in Gorgan, North of Iran. A. fumigatus is the most prevalent and most resistant isolate in the studied area. History of previous agriculture activity and use of pesticides in the proximity of sampling sites may have affected the rate of ITC resistance.
Full-Text [PDF 620 kb]   (93 Downloads)    
Type of Study: Original Paper | Subject: Mycology
Received: 2019/09/23 | Accepted: 2020/01/21 | Published: 2020/06/30 | ePublished: 2020/06/30

References
1. Verweij PE, Snelders E, Kema GH, Mellado E, Melchers WJ. Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use? Lancet Infect Dis. 2009; 9(12): 789-95. doi: 10.1016/S1473-3099(09)70265-8. [DOI:10.1016/S1473-3099(09)70265-8] [PubMed] [Google Scholar]
2. Mortensen KL, Mellado E, Lass-Flörl C, Rodriguez-Tudela JL, Johansen HK, Arendrup MC. Environmental study of azole-resistant Aspergillus fumigatus and other aspergilli in Austria, Denmark, and Spain. Antimicrob Agents Chemother. 2010; 54(11): 4545-9. doi: 10.1128/AAC.00692-10. [DOI:10.1128/AAC.00692-10] [PubMed] [Google Scholar]
3. Verweij PE, Chowdhary A, Melchers WJ, Meis JF. Azole resistance in Aspergillus fumigatus: can we retain the clinical use of mold-active antifungal azoles? Clin Infect Dis. 2016; 62(3): 362-8. doi: 10.1093/cid/civ885. [DOI:10.1093/cid/civ885] [PubMed] [Google Scholar]
4. Vaezi A, Haghani I, Mohammad Davoudi M, Mousavi B, Ansari S, Noshak MA, et al. Azole resistance in Aspergillus fumigatus isolates. Journal of Mazandaran University of Medical Sciences. 2013; 23(103): 120-37. [Google Scholar]
5. Verweij PE, Denning DW. The challenge of invsive aspergillus. Increasing numbers in diverse patient groups. 1997. [DOI:10.1016/S1201-9712(97)90083-7] [Google Scholar]
6. Chowdhary A, Kathuria S, Xu J, Meis JF. Emergence of azole-resistant Aspergillus fumigatus strains due to agricultural azole use creates an increasing threat to human health. PLoS pathogens. 2013; 9(10): e1003633. doi: 10.1371/journal.ppat.1003633. [DOI:10.1371/journal.ppat.1003633] [PubMed] [Google Scholar]
7. Howard SJ, Cerar D, Anderson MJ, Albarrag A, Fisher MC, Pasqualotto AC, et al. Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure. Emerging infectious diseases. 2009; 15(7): 1068. [DOI:10.3201/eid1507.090043] [PubMed] [Google Scholar]
8. Badali H, Vaezi A, Haghani I, Yazdanparast SA, Hedayati MT, Mousavi B, et al. Environmental study of azole‐resistant Aspergillus fumigatus with TR34/L98H mutations in the cyp51A gene in Iran. Mycoses. 2013; 56(6): 659-63. [DOI:10.1111/myc.12089] [PubMed] [Google Scholar]
9. Snelders E, van der Lee HA, Kuijpers J, Rijs AJM, Varga J, Samson RA, et al. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS medicine. 2008; 5(11): e219. [DOI:10.1371/journal.pmed.0050219] [PubMed] [Google Scholar]
10. Chowdhary A, Sharma C, van den Boom M, Yntema JB, Hagen F, Verweij PE, et al. Multi-azole-resistant Aspergillus fumigatus in the environment in Tanzania. Journal of Antimicrobial Chemotherapy. 2014; 69(11): 2979-83. [DOI:10.1093/jac/dku259] [PubMed] [Google Scholar]
11. Jeanvoine A, Rocchi S, Reboux G, Crini N, Crini G, Millon L. Azole‐resistant Aspergillus fumigatus in sawmills of Eastern France. J Appl Microbiol. 2017; 123(1): 172-184. doi: 10.1111/jam.13488. [DOI:10.1111/jam.13488] [PubMed] [Google Scholar]
12. Nabili M, Shokohi T, Moazeni M, Khodavaisy S, Aliyali M, Badiee P, et al. High prevalence of clinical and environmental triazole-resistant Aspergillus fumigatus in Iran: is it a challenging issue? J Med Microbiol. 2016; 65(6): 468-475. doi: 10.1099/jmm.0.000255. [DOI:10.1099/jmm.0.000255] [PubMed] [Google Scholar]
13. Verweij PE, Howard SJ, Melchers WJ, Denning DW. Azole-resistance in Aspergillus: proposed nomenclature and breakpoints. Drug Resist Updat. 2009; 12(6): 141-7. doi: 10.1016/j.drup.2009.09.002. [DOI:10.1016/j.drup.2009.09.002] [PubMed] [Google Scholar]
14. Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2008; 46(3): 327-60. doi: 10.1086/525258. [DOI:10.1086/525258] [PubMed] [Google Scholar]
15. Tsitsopoulou A, Posso R, Vale L, Bebb S, Johnson E, White PL. Determination of the prevalence of triazole resistance in environmental Aspergillus fumigatus strains isolated in South Wales, UK. Front Microbiol. 2018; 9: 1395. doi: 10.3389/fmicb.2018.01395. [DOI:10.3389/fmicb.2018.01395] [PubMed] [Google Scholar]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


© 2007 All Rights Reserved | Medical Laboratory Journal